A detailed history of Badgley Phelps Wealth Managers, LLC transactions in Amgen Inc stock. As of the latest transaction made, Badgley Phelps Wealth Managers, LLC holds 47,005 shares of AMGN stock, worth $13.8 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
47,005
Previous 46,136 1.88%
Holding current value
$13.8 Million
Previous $14.4 Million 5.06%
% of portfolio
0.36%
Previous 0.36%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$309.38 - $337.38 $268,851 - $293,183
869 Added 1.88%
47,005 $15.1 Million
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $1,051 - $1,277
4 Added 0.01%
46,136 $14.4 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $215,096 - $259,648
800 Added 1.76%
46,132 $13.1 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $1.72 Million - $1.94 Million
6,717 Added 17.39%
45,332 $13.1 Million
Q3 2023

Nov 02, 2023

BUY
$218.65 - $271.46 $37,389 - $46,419
171 Added 0.44%
38,615 $10.4 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $24,426 - $28,884
114 Added 0.3%
38,444 $8.54 Million
Q1 2023

Apr 28, 2023

BUY
$225.79 - $275.2 $58,028 - $70,726
257 Added 0.68%
38,330 $9.27 Million
Q4 2022

Jan 27, 2023

BUY
$229.03 - $291.01 $20,154 - $25,608
88 Added 0.23%
38,073 $0
Q3 2022

Nov 09, 2022

BUY
$224.46 - $253.15 $192,137 - $216,696
856 Added 2.31%
37,985 $8.56 Million
Q2 2022

Aug 01, 2022

SELL
$230.71 - $256.74 $33,452 - $37,227
-145 Reduced 0.39%
37,129 $9.03 Million
Q1 2022

May 09, 2022

SELL
$219.27 - $242.57 $117,090 - $129,532
-534 Reduced 1.41%
37,274 $9.01 Million
Q4 2021

Feb 08, 2022

SELL
$198.88 - $227.6 $77,563 - $88,764
-390 Reduced 1.02%
37,808 $8.51 Million
Q3 2021

Nov 29, 2021

BUY
$212.27 - $248.7 $8.11 Million - $9.5 Million
38,198 New
38,198 $8.12 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Badgley Phelps Wealth Managers, LLC Portfolio

Follow Badgley Phelps Wealth Managers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Badgley Phelps Wealth Managers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Badgley Phelps Wealth Managers, LLC with notifications on news.